Conversely, a pilot study showed that reduction of fructose intake by 50% in patients with steatotic liver disease showed significantly decreased hepatic lipid content, plasma transaminase levels, Body Mass Index, fasting plasma insulin, endotoxin concentrations, and plasma plasminogen activator inhibitor-1 (PAI-1) after six months [148]. Here, INS is linked to liver disorder.